KELLI PLUNK: Open Payments
NPI 1265942288 · TUPELO, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,136 in 155 payments from 27 companies in 2025. Trend: 2023 $2,071 · 2024 $2,658 · 2025 $3,136
Food & beverage: $3,136
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 24 | $556 |
| GlaxoSmithKline, LLC. | 33 | $509 |
| HARMONY BIOSCIENCES LLC | 8 | $223 |
| Merck Sharp & Dohme LLC | 9 | $184 |
| GENZYME CORPORATION | 7 | $166 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $164 |
| ANI Pharmaceuticals, Inc. | 6 | $162 |
| JAZZ PHARMACEUTICALS INC. | 5 | $126 |
| Electromed, Inc. | 8 | $117 |
| Grifols USA, LLC | 4 | $115 |
Products named: FASENRA, NUCALA, DUPIXENT, WAKIX, TRELEGY ELLIPTA, PURIFIED CORTROPHIN GEL, ZERBAXA, XYWAV.
Industry payments across MS — which companies pay providers there.
